Immuneering Corporation (IMRX) Total liabilities 2020–2023
Immuneering Corporation (IMRX) total liabilities at each fiscal year-end, per SEC filings.
$12.0MFY2023 · since FY2020: $2.8M → $12.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $12.0M | -4.1% |
| FY2022 | $12.5M | +16.7% |
| FY2021 | $10.7M | +282.9% |
| FY2020 | $2.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice